The Foundation supports canine health research for the future of our breed
We are fortunate that the PBGV is a very healthy breed. A critical aspect of maintaining the breed's health is to educate breeders and owners on prevention, diagnosis, and treatment of health issues relevant to the PBGV. At the same time, we are conscious of the need to support research that will lead to future health advances. Here, we partner with the AKC Canine Health Foundation (CHF).
The Foundation Board of Directors examines the CHF Research Grants Portfolio each spring and sorts through the over 200 (!) abstracts to find those of relevance to PBGV health. Over the years, the grants that we have selected largely represent health issues directly pertinent to our breed (e.g., idiopathic epilepsy, pancreatitis, lens luxation, and glaucoma); however, we also support grants with the potential to have a significant impact on health issues that touch all breeds, including the PBGV (e.g., tick-borne diseases, pyometra, Brucellosis, and cancer).
Research that we have sponsored:
Funded in 2023
Grant 2981 Genome-wide Identification and Characterization of Peptide Epitopes from Ehrlichia canis and Anaplasma platys with Potential to be Used as Vaccine Candidates
Sreekumari Rajeev, BVSc, PhD; University of Tennessee
Learn more HERE.
2983 Enhanced Detection and Characterization of Spotted Fever Group Rickettsia Species in Dogs and Ticks with Focus on a Novel Rickettsia Species Infecting Clinically Ill Dogs in the U.S.
Barbara Qurollo, DVM, MS; North Carolina State University
Learn more HERE.
Grant 3031 Tolerability and Clinical Efficacy of Oral Potassium Chloride Supplementation for Treatment of Hypochloremia in Canine Congestive Heart Failure
Darcy B. Adin, DVM, MS; University of Florida
Learn more HERE.
Grant 3039 Prognostic Biomarkers for the Development of Drug Resistance in Dogs with Idiopathic Epilepsy
Thomas Parmentier, DVM, PhD; Université de Montréal
Learn more HERE.
Grant 3040 Identification of Novel Epilepsy Genes in Dogs
Hannes T. Lohi, PhD; The Folkhälsan Institute of Genetics
Learn more HERE.
Grant 3045-A Artificial Intelligence and Machine Learning for Diagnosis of Dog Sperm Morphology
Leonardo Brito, DVM, PhD; University of Pennsylvania
Learn more HERE.
Grant 3051-A Antimicrobial Resistance in the Canine Vaginal Microbiome
Erika Ganda, DVM, PhD; Pennsylvania State University
Learn more HERE.
Funded in 2022
Grant 2561: Is Gut Dysbiosis Associated with Canine Idiopathic Epilepsy?
Karen R. Muñana, DVM, MS; North Carolina State University
Learn more HERE.
Funded in 2021
CHF 02930: A Dose Finding Study of Cannabidiol in Dogs with Idiopathic Epilepsy.
Stephanie McGrath, DVM, MS from Colorado State University.
Learn more HERE.
CHF 02931: Assessment of Frequency of Seizures and Antiseizure Drug (ASD) Efficacy
by Electroencephalography (EEG) for Dogs with Epilepsy.
Fiona James, DVM, MS from the University of Guelph.
Learn more HERE.
Grant 02875: Canine Pituitary Adenoma Organoids as an in vitro Model
for Canine Cushing's Disease.
Karin Sanders, DVM, PhD from Utrecht University (Netherlands).
Learn more HERE.
Grant 02809: Microbial and Cytokine Signatures of Periodontitis in Dogs.
Santiago Peralta, DVM, from Cornell University.
Learn more HERE.
Grant 02850-A: Potential Reduction of Systemic and Pancreatic Inflammation
using Fenofibrate in Diabetic Dogs.
Dr. Allison O’Kell, DVM, MS, from the University of Florida.
Learn more HERE.
Grant 02851-A: Development of Regional Anesthesia Techniques
to Treat Chronic Painful Conditions of the Stifle and Elbow in Dogs.
Diego A. Portela, DVM, PhD, from the University of Florida.
Learn more HERE.
Grant 02861-A: T Cardiovascular Complications of Acute Pancreatitis in Dogs.
Harry Cridge, MVB, MS, from Michigan State University.
Learn more HERE.
Funded in 2020
CHF 02252: Investigating a Ketogenic Medium-Chain Triglyceride (MCT) Supplement for the Treatment of Drug-Resistant Canine Idiopathic Epilepsy and Its Behavioral Comorbidities
Holger Andreas Volk, DVM, PhD; Royal Veterinary College, University of London
Learn more HERE.
CHF 02323: Efficacy of Cannabidiol (CBD) for the Treatment of Canine Epilepsy
Stephanie McGrath, DVM, MS; Colorado State University
Learn more HERE.
CHF 02489: Tumor-permissive Collagen Signatures in Canine Mammary Gland Tumors: Development of Prognostic Markers and Targeted Therapies for Improved Outcomes
Susan W. Volk, VMD, PhD; University of Pennsylvania
Learn more HERE.
CHF 02534: Clinical Trial for Evaluation of Propranolol and Doxorubicin in the Treatment of Canine Hemangiosarcoma
Erin B. Dickerson, PhD and Antonella Borgatti, DVM, MS; University of Minnesota
Learn more HERE.
CHF 02561: Is Gut Dysbiosis Associated with Canine Idiopathic Epilepsy?
Karen R. Muñana, DVM, MS; North Carolina State University
Learn more HERE.
CHF 02610-A: The Role of Motilin Signaling in Canine Osteoarthritis
Li Zeng, PhD; Tufts University
Learn more HERE.
CHF 02643-A: Examination of the Effects of Cannabidiol on Canine Neoplastic Cell Apoptosis/Autophagy and Potential for Chemotherapy Resistance or Sensitivity
Joseph J. Wakshlag, DVM, PhD; Cornell University
Learn more HERE.
Funded in 2019
CHF 02532-A: Canine Influenza: Occurrence, Spatial and Temporal Trends and Identifying Modifiable Factors to Reduce Transmission at Events in the United States
J Scott Weese, DVM and Jason Stull, VMD, MPVM, PhD; University of Guelph; Ohio State University and University of Prince Edward Island
Learn more HERE.
Funded in 2018
CHF 02323: Efficacy of Cannabidiol (CBD) for the Treatment of Canine Epilepsy
Stephanie McGrath, DVM, MS; Colorado State University
Learn more HERE.
CHF 02528: Developing a Next Generation Sequencing Diagnostic Platform for Tickborne Diseases
Pedro Diniz, DVM, PhD; Western University of Health Sciences
Learn more HERE.
Rabies Challenge Fund
Learn more HERE.
Funded in 2017
CHF 02175-A: Development of a Brucellosis Vaccine for Dogs
Angela M Arenas, DVM, PhD; Texas A&M AgriLife Research
Learn more HERE.
CHF 02238-A: Effect of Platelet Count on Platelet Function Tests in Dogs
Elizabeth Spangler, DVM, PhD; Auburn University
Learn more HERE.
CHF 02241: The City Dog Study: Dermatologic and Respiratory Disease among Inner-City Dogs Living in the Homes of Children with Asthma
Meghan F. Davis, DVM, MPH, PhD; Johns Hopkins University
Learn more HERE.
CHF 02249-A: Studying the Role of the Gastrointestinal Tract in Canine Epilepsy
Karen R. Muñana, DVM; North Carolina State University
Learn more HERE.
CHF 02257: Identification of Genetic Risk Factors for Canine Epilepsy
Gary S. Johnson, DVM, PhD; University of Missouri, Columbia
Learn more HERE.
CHF 02309-T: Targeting the Cancer Epigenome: The Effect of Specific Histone Lysine Methyltransferase Inhibition in Canine B-Cell Lymphoma
Angela McCleary-Wheeler, DVM, PhD; University of Missouri
Learn more HERE.
Funded in 2016
CHF 02128-A: Redefining the Recommendations for Prevention of Infectious Disease at Dog Shows and Other Areas Where Dogs Meet and Compete
Jason Stull, VMD, PhD; Ohio State University
Learn more HERE.
CHF 02161-A: Supporting the Evidence-Based Use of Antibiotic Gels after Extensive Dental Plaque Removal in Dogs
Django Martel, DVM; The Animal Medical Center
Learn more HERE.
CHF 2217: A Novel Mechanism to Regulate the Growth of Canine Hemangiosarcoma
Erin B. Dickerson, PhD; University of Minnesota
Learn more HERE.
CHF 02237-A: Capturing Tumor Cells in Canine Blood
Tracy Stokol, PhD; Cornell University
Learn more HERE.
CHF 2252: Canine Epilepsy: Determining the Mode of Inheritance, Mapping the Genes, and Developing a Linkage Test
James R. Mickelson, PhD; University of Minnesota
Learn more HERE.
CHF 02284-A: Lyme Disease in Dogs: Prevalence, Clinical Illness, and Prognosis
Thomas Wittum, MS, PhD; Andréia Arruda, DVM, MSc, PhD; Jason Stull, VMD, MPVM, PhD; The Ohio State University and University of Prince Edward Island
Learn more HERE.